<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="135987">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01660880</url>
  </required_header>
  <id_info>
    <org_study_id>C-1205-094-410</org_study_id>
    <secondary_id>A070001</secondary_id>
    <nct_id>NCT01660880</nct_id>
  </id_info>
  <brief_title>Validation of Receptor Occupancy Simulation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  To estimate dopamine receptor occupancy by aripiprazole using computer simulation

        -  To measure dopamine receptor occupancy by aripiprazole in patients treated with the
           antipsychotics

        -  To validate the simulation result by comparing the receptor occupancy from the
           simulation with that from the patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Dopamine receptor occupancy</measure>
    <time_frame>72 hrs after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured using 11C-raclopride positron emission tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hamilton rating scale for depression</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>HAM-D score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barnes akathisia scale</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>BAS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abnormal involuntary movement scale</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>AIMS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simpson-Angus scale</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>SAS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment satisfaction questionnaire for medication</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>TSQM score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication satisfaction questionnaire</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>MSQ score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N-back task</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>To measure the change in working memory performance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolactin level</measure>
    <time_frame>Baseline and 72 hours after the last administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>To explore the effect of receptor occupancy on the blood prolactin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dopamine receptor occupancy</measure>
    <time_frame>3 hrs after the last administration</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dopamine receptor occupancy</measure>
    <time_frame>24 hrs after the last administration</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Dopamine Receptor Occupancy</condition>
  <condition>Medication Satisfaction</condition>
  <condition>Prolactin Level</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>aripiprazole</arm_group_label>
    <description>Patient group who is treated with aripiprazole</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with schizophrenia who is in the steady sate of antipsychotic treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of schizophrenia

          -  treated with aripiprazole or risperidone

          -  no change in dose of antipsychotics for at least 6 weeks

          -  total PANSS score should be below 80

        Exclusion Criteria:

          -  Other psychiatric disorders rather than schizophrenia

          -  history of head trauma

          -  positive in urine hCG

          -  on antidepressant, anticholinergics or mood stabilizer
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun Soo Kwon, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Euitae Kim, M.D., Ph.D.</last_name>
    <phone>82-10-9419-1058</phone>
    <email>euitae.kim@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Euitae Kim, M.D., Ph.D.</last_name>
      <phone>82-10-9419-1058</phone>
      <email>euitae.kim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Euitae Kim, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 18, 2013</lastchanged_date>
  <firstreceived_date>July 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jun Soo Kwon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aripiprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
